Comparison of the injection‐site experience of the starting doses with semaglutide and dulaglutide: A randomized, double‐blind trial in healthy subjects

This double‐blind, randomized, single‐site, crossover trial compared the injection‐site experience with the starting doses of semaglutide and dulaglutide. Healthy subjects (aged 18–75 years; body mass index ≥ 25 kg/m(2); n = 104) were randomized 1:1, using a pregenerated list, to semaglutide 0.25 mg...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Obes Metab
Hlavní autoři: Snitker, Søren, Andersen, Andreas, Berg, Birgitte, van Marle, Sjoerd, Sparre, Thomas
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2021
Témata:
Brief Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8251561/
https://ncbi.nlm.nih.gov/pubmed/33591618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14349
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky